TITLE

New children's vaccines, new direction

AUTHOR(S)
Kassianos, George
PUB. DATE
January 2007
SOURCE
GP: General Practitioner;1/12/2007, p30
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on issues related to the introduction of routine immunization of infants against pneumococcal disease in Great Britain. The new immunization schedule was announced on June 12, 2006. One of the problems of introducing a new vaccine is how to fit another vaccine into the immunization schedule. The anti-vaccination lobbies accuse immunization policy makers of overloading the children's immune system by introducing more vaccines.
ACCESSION #
23770300

 

Related Articles

  • Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands. Rodenburg, Gerwin D.; de Greeff, Sabine C.; Jansen, Angelique G. C. S.; de Melker, Hester E.; Schouls, Leo M.; Hak, Eelko; Spanjaard, Lodewijk; Sanders, Elisabeth A. M.; van der Ende, Arie // Emerging Infectious Diseases;May2010, Vol. 16 Issue 5, p816 

    In the Netherlands, the 7-valent pneumococcal conjugate vaccine (PCV-7) was implemented in a 3+1-dose schedule in the national immunization program for infants born after April 1, 2006. To assess the vaccine's effectiveness, we compared disease incidence before and after vaccine implementation...

  • Pneumococcal Immunization: From Policy to Practice. Schwartz, Benjamin; Breiman, Robert F. // JAMA: Journal of the American Medical Association;9/5/90, Vol. 264 Issue 9, p1154 

    Editorial. Deals with the low utilization of pneumococcal vaccines targeted for adults in the U.S. Factors behind the lack of use of pneumococcal vaccines; Strategies that can be adopted to increase utilization of pneumococcal vaccines; Cost benefits of immunization.

  • Prevenar joins schedule in June. Reid, Stewart // New Zealand Doctor;5/7/2008, p17 

    The article focuses on the use of Prevenar as vaccine. According to the author, starting June 1, 2008 heptavalent conjugate pneumococcal vaccine Prevenar will be part of the New Zealand routine immunization schedule. The immunization will have a four-dose schedule with doses at six weeks, three,...

  • General considerations.  // WHO Technical Report Series;2004, Issue 927, p66 

    The article focuses on polysaccharide vaccines for infections caused by Streptococcus pneumoniae, which are responsible for substantial morbidity and mortality, commonly on children and the elderly. Pneumociccus are classified based on chemical and serological distinct capsular polysaccharides....

  • Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6C. Park, In H.; Moore, Matthew R.; Treanor, John J.; Pelton, Stephen I.; Pilishvili, Tamara; Beall, Bernard; Shelly, Mark A.; Mahon, Barbara E.; Nahm, Moon H. // Journal of Infectious Diseases;12/15/2008, Vol. 198 Issue 12, p1818 

    Background. Because classic pneumococcal serotyping methods cannot distinguish between serotypes 6A and 6C, the effects of pneumococcal vaccines against serotype 6C are unknown. Pneumococcal vaccines contain serotype 6B but not serotypes 6A and 6C. Methods. We used a phagocytic killing assay to...

  • Indirect Effect of 7-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in Newborns in Rural Gambia: A Randomised Controlled Trial. Egere, Uzochukwu; Townend, John; Roca, Anna; Akinsanya, Abiodun; Bojang, Abdoulie; Nsekpong, David; Greenwood, Brian; Adegbola, Richard A.; Hill, Philip C. // PLoS Clinical Trials;Nov2012, Vol. 7 Issue 11, p1 

    Background: Gambian infants frequently acquire Streptococcus pneumoniae soon after birth. We investigated the indirect effect of 7-valent pneumococcal conjugate vaccine (PCV-7) on pneumococcal acquisition in newborn Gambian babies. Methods: Twenty-one villages were randomised to receive...

  • Multilocus sequence types of invasive pneumococcal isolates from Danish infants (0-90 days) 2003-2013. Slotved, Hans-Christian; Dalby, Tine; Hoffmann, Steen // BMC Research Notes;10/14/2015, p1 

    Background: A pneumococcal conjugate vaccine (PCV) has been part of the Danish childhood immunization programme since October 2007. It is administered at the ages of 3, 5 and 12 months and healthy infants younger than 90 days are consequently not vaccinated. Initially the PCV-7 vaccine was used...

  • Transmission of Streptococcus pneumoniaein Rural Gambian Villages: A Longitudinal Study. Hill, Philip C.; Townend, John; Antonio, Martin; Akisanya, Biodun; Ebruke, Chinelo; Lahai, George; Greenwood, Brian M.; Adegbola, Richard A. // Clinical Infectious Diseases;6/1/2010, Vol. 50 Issue 11, p1468 

    Background. To prepare for national introduction of a pneumococcal vaccine of restricted valency, we studied the pattern of nasopharyngeal carriage of Streptococcus pneumoniae and its transmission in Gambian villages over time. Methods. We collected nasopharyngeal swab specimens every 2 weeks...

  • Increased Penicillin Nonsusceptibility of Nonvaccine-Serotype Invasive Pneumococci Other than Serotypes 19A and 6A in Post-7-Valent Conjugate Vaccine Era. Gertz Jr., Robert E.; Zhongya Li; Pimenta, Fabiana C.; Jackson, Delois; Juni, Billie A.; Lynfield, Ruth; Jorgensen, James H.; da Gloria Carvalho, Maria; Beall, Bernard W. // Journal of Infectious Diseases;3/1/2010, Vol. 201 Issue 5, p770 

    According to population-based invasive pneumococcal surveillance in the United States during 2007, 898 (26%) of 3,511 isolates were penicillin nonsusceptible. Non-7-valent pneumococcal conjugate vaccine (PCV7) serotypes other than 19A accounted for 40% of these penicillin-nonsusceptible...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics